Movement Disorders
Livin' on the MDedge
Even COVID-19 can’t stop a true optimist
Plus: Cheese and sleep may not mix, but golf and Parkinson’s do.
From the Journals
Ferric carboxymaltose calms restless legs
Nearly two-thirds of patients with restless legs syndrome remained off RLS medications at 1 year after treatment.
Literature Review
Parkinson’s death rate rising, reasons unclear
“Understanding why more people are dying from this disease is critical if we are going to reverse the trend.”
Latest News
Influenza tied to long-term increased risk for Parkinson’s disease
“The infection could be a ‘primer’ or an initial ‘hit’ to the system, maybe setting people up for PD.”
From the Journals
Avoidant attachment style may drive mood in movement disorders
High rates of depression found in patients with functional neurological disorders associated with avoidance of close relationships.
From the Journals
Therapeutic homework adherence improves tics in Tourette’s disorder
After eight sessions of behavior therapy, overall greater homework adherence significantly predicted reduced tic severity.
Conference Coverage
A safer way to use Botox to treat challenging dystonia type?
A critical anatomical variation is still unrecognized by most clinicians performing botulinum toxin injections for oromandibular dystonia.
Conference Coverage
Worsening motor function tied to post COVID syndrome in Parkinson’s disease
About half of the study participants with Parkinson’s disease who developed post–COVID-19 syndrome experienced worsening motor symptoms and needed...
Conference Coverage
Novel drug effective for essential tremor, but with significant side effects
Patients receiving the drug saw significant reduction in upper-limb tremors, but adverse events led many to discontinue treatment.
Conference Coverage
Apple devices identify early Parkinson’s disease
Study results show clear differences in a finger-tapping task in the Parkinson’s disease versus control group.
Conference Coverage
Study identifies pandemic-related stressor in Parkinson’s disease
Researchers in the Netherlands identified COVID-19–related stressors for people with Parkinson’s disease and the most vulnerable subgroups.